Differential diagnosis of uremic pseudoperitonitis and peritonitis in patients on renal replacement therapy

Zurnadzhyants V.A.

Astrakhan State Medical University

Kchibekov E.A.

Astrakhan State Medical University

Odishelashvili G.D.

Astrakhan State Medical University

Gasanov K.G.

Astrakhan State Medical University

Differential diagnosis of uremic pseudoperitonitis and peritonitis in patients on renal replacement therapy

Authors:

Zurnadzhyants V.A., Kchibekov E.A., Odishelashvili G.D., Gasanov K.G.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2022;(1): 50‑53

DOI: 10.17116/hirurgia202201150

Downloaded: 57

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zurnadzhyants VA, Kchibekov EA, Odishelashvili GD, Gasanov KG. Differential diagnosis of uremic pseudoperitonitis and peritonitis in patients on renal replacement therapy. Pirogov Russian Journal of Surgery. 2022;(1):50‑53. (In Russ.)
https://doi.org/10.17116/hirurgia202201150

Подписка 2025-2 (Pirogov Russian Journal of Surgery)

Close metadata

OBJECTIVE

To analyze serum concentration of β₂-microglobulin (β₂-MG) and C-reactive protein (CRP) in patients on renal replacement therapy for differential diagnosis of uremic pseudoperitonitis and peritonitis.

MATERIAL AND METHODS

The study included 76 patients on renal replacement therapy who admitted to the hospital with suspected peritonitis. The control group comprised 60 outpatients on renal replacement therapy. We excluded patients with suspected peritonitis who did not receive previous renal replacement therapy. In both groups, we analyzed serum concentration of β₂-MG and CRP.

RESULTS

Among patients with previous renal replacement therapy, the highest concentration of β₂-MG was found in those with suspected uremic pseudoperitonitis, and the highest concentration of CRP was in patients with suspected peritonitis. There were no significant changes in serum concentrations of β₂-MG and CRP in the control group.

Keywords:

uremic pseudoperitonitis

peritonitis

renal replacement therapy

β2-microglobulin

C-reactive protein

Authors:

Zurnadzhyants V.A.

Astrakhan State Medical University

Kchibekov E.A.

Astrakhan State Medical University

Odishelashvili G.D.

Astrakhan State Medical University

Gasanov K.G.

Astrakhan State Medical University

Received:

31.03.2021

Accepted:

27.07.2021

List of references:

Zemchenkov AYu, Tomilina NA. “K/DOQI” refers to the origins of chronic renal failure (about the new K/DOQI section on the diagnosis, classification and assessment of the severity of chronic kidney disease. Nephrology and Dialysis. 2004;3:204-220. (In Russ.).
Tomilina NA, Andrusev AM, Peregudova NG, Shinkarev MB. Replacement therapy of end-stage chronic renal failure in the Russian Federation in 2010-2015. Report on the data of the All-Russian Register of Renal Replacement Therapy of the Russian Dialysis Society. Nephrology and Dialysis. 2018;19(4):1-95. (In Russ.). https://doi.org/10.28996/1680-4422-2017-4
Levey AS, Coresh J, Balk E. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-147. https://doi.org/10.7326/0003-4819-139-2-200307150-00013
Abramova EE, Koroleva IE, Tov N L, Movchan EA, Naborshchikov DA. Death risk factors in patients on hemodialysis. Journal of Siberian Medical Sciences. 2015;6:15-18. (In Russ.).
Bikbov BT, Tomilina NA. Substitution therapy for patients with chronic renal failure in the Russian Federation in 1998-2011. Nephrology and Dialysis. 2014;16(1):13-29. (In Russ.).
Savelyev VS, Gelfand BR, Filimonov MI. Peritonitis. Practical guide. 2006. (In Russ.).
Vatazin AV, Losev GYu, Filizhanko VN, Shumsky VI, Yankovoy AG, Smolyakov AA, Martynyuk AP. Application of minimally invasive surgical interventions in patients with terminal chronic renal failure receiving peritoneal dialysis. Almanac of Clinical Medicine. 2005;8(4):18-25. (In Russ.).
Vatazin AV, Filizhanko VN, Losev GYu, Astakhov PV, Yankovoy AG, Smolyakov AA, Kulibaba SA, Pichugin IS. Laparoscopic operations in patients with terminal chronic renal failure receiving peritoneal dialysis. Almanac of Clinical Medicine. 2007;XVI(4):112116. (In Russ.).
Yankovoy AG, Vatazin AV, Astakhov PV, Smolyakov AA, Shuvalova VV, Kulibaba SA, Nesterenko IV, Losev GYu. Features of the treatment of peritonitis in patients with polycystic kidney disease who are treated with constant outpatient peritoneal dialysis. Nephrology and Dialysis. 2007;9(3):300-301. (In Russ.).
Bikbov BT, Tomilina NA. Composition of patients and indicators of the quality of treatment on replacement therapy for end-stage chronic renal failure in the Russian Federation in 1998-2013. Report on the data of the register of renal replacement therapy of the Russian Dialysis Society. Nephrology and Dialysis. 2016;18(2):123-127. (In Russ.).
Polyakov DS, Shavlovsky MM. Molecular basis of β2-microglobular amyloidosis. Medical Academic Journal. 2014;14(1):24-41. (In Russ.).
Jaques DA, Davenport A. Serum β2-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients. J Nephrol. 2021;34(2):473-481. https://doi.org/10.1007/s40620-020-00906-x
Li T, Wilcox CS, Lipkowitz MS, Gordon-Cappitelli J, Dragoi S. Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients. Am J Nephrol. 2019;50(6):411-421. https://doi.org/10.1159/000503805
Lutseva OA, Zurnadzhyants VA, Kchibekov EA, Musagaliev AA, Kokhanov AV. Possibilities of serum indicator enzymes in the differential diagnosis of atypical forms of acute appendicitis. Bulletin of Surgical Gastroenterology. 2018;5:611-612. (In Russ.).
Minaev SV, Isaeva AV, Obedin AN, Bolotov YuN, Bochnyuk EA, Chintaeva LA, Gudiev ChG. C-reactive protein is the main marker of the dynamics of the course of acute inflammatory processes in clinical conditions. Medical Bulletin of the North Caucasus. 2011;2:95-99. (In Russ.)
Coca S, Parikh C. Urinary Biomarkers for Acute Kidney Injury: Perspectiveson Translation. Clin J Am Soc Nephrol. 2008;3(2):481-490. https://doi.org/10.2215/cjn.03520807
Deegens J, Wetzels J. Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis. Clin Nephrol. 2007;68(4):201-208. https://doi.org/10.5414/cnp68201
Kamiya T, Hirako M, Misu N. Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J of Gastroenterol. 2005;40(12):1116-1122. https://doi.org/10.1007/s00535-005-1709-6
Matsuo N, Yokoyama K, Maruyama Y, Ueda Y, Yoshida H, Tanno Y, Yamamoto R, Terawaki H, Ikeda M, Hanaoka K, Yamamoto H, Ogura M, Watanabe S, Kimura Y, Hosoya T. Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. Clin Nephrol. 2010;74(9):209-216. https://doi.org/10.5414/cnp74209

Close metadata